Matches in Wikidata for { <http://www.wikidata.org/entity/Q97535429> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- Q97535429 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97535429 description "scientific article published on 13 July 2020" @default.
- Q97535429 description "wetenschappelijk artikel" @default.
- Q97535429 description "наукова стаття, опублікована 13 липня 2020" @default.
- Q97535429 name "Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease" @default.
- Q97535429 name "Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease" @default.
- Q97535429 type Item @default.
- Q97535429 label "Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease" @default.
- Q97535429 label "Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease" @default.
- Q97535429 prefLabel "Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease" @default.
- Q97535429 prefLabel "Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease" @default.
- Q97535429 P1433 Q97535429-A5838FB1-632A-450B-916F-AADEFCDA8C07 @default.
- Q97535429 P1476 Q97535429-6C634640-EEE4-488F-B607-A551008228AC @default.
- Q97535429 P2093 Q97535429-19DD318D-55D1-4AAC-8DD6-1F985527F2EB @default.
- Q97535429 P2093 Q97535429-1CC1F99D-2450-4E0F-83BE-B541537D5FFD @default.
- Q97535429 P2093 Q97535429-1EF68F57-6730-40DB-B4D2-AE3E6FC7EDEC @default.
- Q97535429 P2093 Q97535429-2635D873-9DE8-4F73-A868-E46464CDF3C7 @default.
- Q97535429 P2093 Q97535429-47ED26AD-1E6A-4248-9F1D-2E20E5EDF164 @default.
- Q97535429 P2093 Q97535429-4C9FE4A7-16D8-4FA4-8F7D-8921D3264501 @default.
- Q97535429 P2093 Q97535429-53C840C2-FB97-4653-A9DD-C5685565FCBD @default.
- Q97535429 P2093 Q97535429-54E0DF27-13AE-4884-9E95-F6DE45E1DB83 @default.
- Q97535429 P2093 Q97535429-5CAC15BB-A51F-41CF-A8EE-28C480FBA0F7 @default.
- Q97535429 P2093 Q97535429-5F1669AC-6EB4-4E68-A38C-9AD8E2A10B4D @default.
- Q97535429 P2093 Q97535429-63CCE449-26CF-48C7-AC45-FB6E2D4319B4 @default.
- Q97535429 P2093 Q97535429-8FC8DD6E-93B6-43C6-A4B1-F1500D819AC4 @default.
- Q97535429 P2093 Q97535429-CDF0F508-9406-42F0-96D0-FD6A6CA175F5 @default.
- Q97535429 P2093 Q97535429-E4AB5BCF-1CEA-4E98-AA5A-440FF63D154F @default.
- Q97535429 P2093 Q97535429-F1BFDB8E-124B-412B-A61E-ABFFB1F2245D @default.
- Q97535429 P31 Q97535429-A3DBF952-4A24-46F9-AE0F-E9D527A022AC @default.
- Q97535429 P356 Q97535429-AE580BC5-3AD3-4DE8-A3D5-393BFAE9E7AF @default.
- Q97535429 P50 Q97535429-050C617C-94DA-421F-85F7-85F880268B4A @default.
- Q97535429 P50 Q97535429-1AC8061B-CB89-4C78-950F-2096431D0C31 @default.
- Q97535429 P50 Q97535429-600958A2-A8A5-42EA-99F7-836E18BC0A0B @default.
- Q97535429 P50 Q97535429-98D39DA7-EACD-435F-906D-801E39D8F178 @default.
- Q97535429 P50 Q97535429-9956F2AA-5C6F-46D3-AB8B-92F912CDB89E @default.
- Q97535429 P50 Q97535429-BD9271B7-9AA7-4D5A-A8A4-4B910F1B7DA0 @default.
- Q97535429 P50 Q97535429-C10CD8C6-D8C5-4A94-9189-5D7E5A36361D @default.
- Q97535429 P50 Q97535429-CD6FB2FE-CB5F-43EA-83FE-E1C1E3ECD8A7 @default.
- Q97535429 P50 Q97535429-D8111381-EB34-47DE-9580-F70F42B5F973 @default.
- Q97535429 P50 Q97535429-F2546D79-F424-416D-A9A0-2474DB6E9A84 @default.
- Q97535429 P50 Q97535429-F2980419-7CF8-4963-9BFD-5619A96DBC29 @default.
- Q97535429 P577 Q97535429-14736BCE-E8DC-4975-904E-31224D32BB93 @default.
- Q97535429 P698 Q97535429-3FAE3287-4E7D-4846-A859-BFB93AF003F4 @default.
- Q97535429 P921 Q97535429-3A999F6F-9525-4740-9B5B-EEE18A337DFE @default.
- Q97535429 P356 APT.15921 @default.
- Q97535429 P698 32656800 @default.
- Q97535429 P1433 Q4726656 @default.
- Q97535429 P1476 "Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease" @default.
- Q97535429 P2093 "Bo Shen" @default.
- Q97535429 P2093 "Brigid Boland" @default.
- Q97535429 P2093 "Corey A Siegel" @default.
- Q97535429 P2093 "Dana Lukin" @default.
- Q97535429 P2093 "David Hudesman" @default.
- Q97535429 P2093 "Eugenia Shmidt" @default.
- Q97535429 P2093 "Gursimran Kochhar" @default.
- Q97535429 P2093 "Karen Lasch" @default.
- Q97535429 P2093 "Ronghui Xu" @default.
- Q97535429 P2093 "Sashidhar Varma" @default.
- Q97535429 P2093 "Shannon Chang" @default.
- Q97535429 P2093 "Sunanda Kane" @default.
- Q97535429 P2093 "VICTORY Collaboration" @default.
- Q97535429 P2093 "Vipul Jairaith" @default.
- Q97535429 P2093 "Yiran Zhang" @default.
- Q97535429 P31 Q13442814 @default.
- Q97535429 P356 "10.1111/APT.15921" @default.
- Q97535429 P50 Q29922058 @default.
- Q97535429 P50 Q51140510 @default.
- Q97535429 P50 Q56065843 @default.
- Q97535429 P50 Q64364605 @default.
- Q97535429 P50 Q87754904 @default.
- Q97535429 P50 Q87754907 @default.
- Q97535429 P50 Q88386928 @default.
- Q97535429 P50 Q88386930 @default.
- Q97535429 P50 Q90451442 @default.
- Q97535429 P50 Q91259503 @default.
- Q97535429 P50 Q97535419 @default.
- Q97535429 P577 "2020-07-13T00:00:00Z" @default.
- Q97535429 P698 "32656800" @default.
- Q97535429 P921 Q1472 @default.